Evaluation of circulating cell‑free DNA as a molecular monitoring tool in patients with metastatic cancer-Reference-Cited by-同舟云学术

Evaluation of circulating cell‑free DNA as a molecular monitoring tool in patients with metastatic cancer

Published:2019-12-09 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Hufnagl Clemens¹,Leisch Michael²,Weiss Lukas²,Melchardt Thomas²,Moik Martin²,Asslaber Daniela²,Roland Geisberger²,Steininger Philipp³,Meissnitzer Thomas⁴,Neureiter Daniel¹,Greil Richard²,Egle Alexander²

Affiliation:

1. Institute of Pathology, Paracelsus Medical University Salzburg, A‑5020 Salzburg, Austria

2. IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, A‑5020 Salzburg, Austria

3. Institute for Research and Development on Advanced Radiation Technologies, Paracelsus Medical University Salzburg, A‑5020 Salzburg, Austria

4. Institute of Radiology, Paracelsus Medical University Salzburg, A‑5020 Salzburg, Austria

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Pancreatic Cancer Detection: Integrating Biomarkers, Imaging Technologies, and Machine Learning for Early Diagnosis;Cureus;2024-03-20

2. The kinetics of circulating cell-free DNA to predict the clinical efficacy of first-line chemotherapy in patients with metastatic colorectal cancer;2022-09-06

3. The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs;Journal of Translational Medicine;2022-08-16

4. Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer;Pancreatology;2021-12

5. Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?;Journal of Oncology;2021-04-12